Glaxo Loses Patent For Seretide/Advair In U.K.
By Marius Meland · March 19, 2004, 12:00 AM EST
GlaxoSmithKline has lost a U.K. patent challenge from generic drug makers Cipla and Ivax on its top-selling athma drug Seretide (Advair)....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login